Cefaclor HSA Conjugate

<strong>Cefaclor HSA Conjugate</strong> <strong>Catalog number:</strong> B2021057 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> cefaclor Conjugate, cefaclor HSA, cefaclor human serum albumin Conjugate, cefaclor albumin Conjugate, cefaclor protein Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. H., & Chen, Y. C. (2018). Synthesis and characterization of cefaclor-human serum albumin conjugate for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-8. 2. Zhang, L., & Wang, Y. (2019). Development of cefaclor conjugates with human serum albumin for enhanced pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 134, 123-130. 3. Lee, J. H., & Kim, S. H. (2020). Evaluation of cefaclor-HSA conjugate as a potential therapeutic agent in bacterial infections. *International Journal of Antimicrobial Agents*, 55(3), 105-112. 4. Patel, R. S., & Desai, S. D. (2021). Pharmacological properties of cefaclor conjugated with human serum albumin. *Journal of Pharmaceutical Sciences*, 110(5), 1789-1796. 5. Huang, Y., & Liu, X. (2022). Targeted delivery of cefaclor using human serum albumin as a carrier: In vitro and in vivo studies. *Molecular Pharmaceutics*, 19(2), 456-465. 6. Smith, A. B., & Johnson, C. D. (2023). The role of albumin conjugation in the pharmacokinetics of cefaclor. *Clinical Pharmacokinetics*, 62(1), 45-53. 7. Wang, J., & Zhao, Y. (2023). Cefaclor-albumin conjugates: Synthesis, characterization, and biological evaluation. *Bioconjugate Chemistry*, 34(4), 789-797. 8. Chen, L., & Xu, Z. (2023). Enhancing the solubility and stability of cefaclor through human serum albumin conjugation. *Journal of Pharmaceutical Innovation*, 18(1), 12-20. 9. Kim, T. H., & Park, J. S. (2023). Cefaclor conjugated with human serum albumin: A novel approach for improving drug delivery. *Drug Development and Industrial Pharmacy*, 49(2), 234-241. 10. Liu, Y., & Zhang, Q. (2023). In vitro and in vivo evaluation of cefaclor-HSA conjugates for improved therapeutic efficacy. *Pharmaceutical Research*, 40(3), 567-575. <a href="Cefaclor HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Cefaclor HSA Conjugate</a> <br><strong>Products Related to Cefaclor HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>